Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3400)
All Articles published online
|
Oct 21, 2009 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15(39): 4962-4968 [PMID: 19842230 DOI: 10.3748/wjg.15.4962] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i39/4962.htm |
| Number | Citing Articles |
| 1 |
Alberto Di Leo, Andrea Zanoni. Siewert III adenocarcinoma: treatment update. Updates in Surgery 2017; 69(3): 319 doi: 10.1007/s13304-017-0429-9
|
| 2 |
Kfir Ben-David, George A. Sarosi, Juan C. Cendan, Drew Howard, Georgios Rossidis, Steven N. Hochwald. Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomies. Surgical Endoscopy 2012; 26(1): 162 doi: 10.1007/s00464-011-1846-3
|
| 3 |
Felice Pasini, Anna Paola Fraccon, Giovanni de Manzoni. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma. Updates in Surgery 2012; : 131 doi: 10.1007/978-88-470-2330-7_12
|
| 4 |
MICHELE ORDITURA, GENNARO GALIZIA, ALESSIO FABOZZI, EVA LIETO, VALENTINA GAMBARDELLA, FLORIANA MORGILLO, GIAN MATTIA DEL GENIO, LANDINO FEI, NATALE DI MARTINO, ANDREA RENDA, FORTUNATO CIARDIELLO, FERDINANDO DE VITA. Preoperative treatment of locally advanced esophageal carcinoma. International Journal of Oncology 2013; 43(6): 1745 doi: 10.3892/ijo.2013.2118
|
| 5 |
Maxim Le Compte, Niels Komen, Ines Joye, Marc Peeters, Hans Prenen, Evelien Smits, Christophe Deben, Michiel de Maat. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies. Critical Reviews in Oncology/Hematology 2021; 157: 103190 doi: 10.1016/j.critrevonc.2020.103190
|
| 6 |
Suun Sathornviriyapong, Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, Nobuyuki Sakurazawa, Yoichi Kawano, Marina Yamada, Eiji Uchida. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis. Annals of Surgical Oncology 2016; 23(11): 3632 doi: 10.1245/s10434-016-5298-9
|
| 7 |
Bernhard J. Leibl, Stephanie Vitz, Wolfgang Schäfer, Martin Alfrink, Andreas Gschwendtner, Gerhard G. Grabenbauer. Adenocarcinoma of the esophagogastric junction: Neoadjuvant radiochemotherapy and radical surgery. Strahlentherapie und Onkologie 2011; 187(4): 231 doi: 10.1007/s00066-011-2171-4
|
| 8 |
M.C.C.M. Hulshof, H.W.M. van Laarhoven. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction. Best Practice & Research Clinical Gastroenterology 2016; 30(4): 551 doi: 10.1016/j.bpg.2016.06.002
|
| 9 |
Fang Li, Tao Li, Li Liu, Jiahua Lv, Yanqiong Song, Churong Li, Peng Diao. Concurrent versus Sequential Chemoradiotherapy for Esophageal Cancer among Chinese Population: A Meta-Analysis. Tumori Journal 2015; 101(4): 353 doi: 10.5301/tj.5000314
|
| 10 |
Junko Kuroda, Masashi Yoshida, Masaki Kitajima, Akio Yanagisawa, Toshiki Matsubara, Toshiharu Yamaguchi, Yoshiyuki Osamura, Keiichirou Ohta, Keisuke Kubota, Yoshifumi Beck, Yuichi Yamashita. Utility of preoperative chemoradiotherapy for advanced esophageal carcinoma. Journal of Gastroenterology and Hepatology 2012; 27(s3): 88 doi: 10.1111/j.1440-1746.2012.07078.x
|
| 11 |
Priyanka Sethi, BD Vaishnavi, Manbir Kaur, Tanvi Meshram. Unexpected aortic tear: Nightmare for the anesthesiologist. Saudi Journal of Anaesthesia 2022; 16(1): 140 doi: 10.4103/sja.sja_730_21
|
| 12 |
JUN SOBAJIMA, KENSUKE KUMAMOTO, NORIHIRO HAGA, JUNICHI TAMARU, TAKEO TAKAHASHI, TATSUYA MIYAZAKI, HIDEYUKI ISHIDA. Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinoma. Oncology Letters 2012; 3(2): 287 doi: 10.3892/ol.2011.468
|
| 13 |
N. Schuring, W.T. Stam, V.D. Plat, M.C. Kalff, M.C.C.M. Hulshof, H.W.M. van Laarhoven, S. Derks, D.L. van der Peet, M.I. van Berge Henegouwen, F. Daams, S.S. Gisbertz. Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center. European Journal of Surgical Oncology 2023; 49(10): 106947 doi: 10.1016/j.ejso.2023.05.022
|
| 14 |
A. Zanoni, G. Verlato, S. Giacopuzzi, J. Weindelmayer, F. Casella, F. Pasini, E. Zhao, G. de Manzoni. Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. Annals of Surgical Oncology 2013; 20(6): 1993 doi: 10.1245/s10434-012-2822-4
|
| 15 |
Su Q. Li, He M. Wang, Xiu F. Cao. Potential clinical insights into microRNAs and their target genes in esophageal carcinoma. Biomarkers 2011; 16(8): 629 doi: 10.3109/1354750X.2011.608132
|
| 16 |
Pierfrancesco Franco, Francesca Arcadipane, Paolo Strignano, Rosella Spadi, Elisabetta Trino, Stefania Martini, Giuseppe Carlo Iorio, Maria Antonietta Satolli, Mario Airoldi, Renato Romagnoli, Michele Camandona, Umberto Ricardi. Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials. Medical Oncology 2017; 34(3) doi: 10.1007/s12032-017-0898-1
|
| 17 |
Hyun Chang, Sung Kwan Shin, Byoung Chul Cho, Chang-Geol Lee, Choong Bai Kim, Dae Joon Kim, Jin Gu Lee, Jin Hur, Chang Young Lee, Mi Kyung Bae, Hye Ryun Kim, Sang Kil Lee, Jun Chul Park, Hyuk Lee, Hyoung-Il Kim, Hyunsoo Chung, Jihye Cha, Yong Chan Lee, Joo-Hang Kim. A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer. Cancer Chemotherapy and Pharmacology 2014; 73(4): 665 doi: 10.1007/s00280-013-2371-y
|
| 18 |
Amit Javed, Sujoy Pal, Gaurav Nitin Chaubal, Peush Sahni, Tushar Kanti Chattopadhyay. Management and Outcome of Intrathoracic Bleeding due to Vascular Injury During Transhiatal Esophagectomy. Journal of Gastrointestinal Surgery 2011; 15(2): 262 doi: 10.1007/s11605-010-1375-8
|
| 19 |
Kfir Ben-David, George Rossidis, Robert A. Zlotecki, Stephen R. Grobmyer, Juan C. Cendan, George A. Sarosi, Steven N. Hochwald. Minimally Invasive Esophagectomy is Safe and Effective Following Neoadjuvant Chemoradiation Therapy. Annals of Surgical Oncology 2011; 18(12): 3324 doi: 10.1245/s10434-011-1702-7
|
| 20 |
Heidi Furlong, Gary Bass, Oscar Breathnach, Brian O'Neill, Eamonn Leen, Thomas N. Walsh. Targeting therapy for esophageal cancer in patients aged 70 and over. Journal of Geriatric Oncology 2013; 4(2): 107 doi: 10.1016/j.jgo.2012.12.006
|
| 21 |
Valdir Tercioti Jr, Luiz Roberto Lopes, João de Souza Coelho-Neto, Nelson Adami Andreollo. Terapêutica neo-adjuvante aumenta as complicações pós-operatórias da esofagectomia?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2010; 23(3): 168 doi: 10.1590/S0102-67202010000300008
|
| 22 |
Nida Akgul, Abdullah Sakin, Suleyman Sahin, Mehmet Naci Aldemir, Aydin Aytekin, Murat ALAY, Umit Haluk Iliklerden, Mehmet Cetin Kotan. Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma. Journal of Gastrointestinal Cancer 2022; 53(2): 439 doi: 10.1007/s12029-021-00631-z
|
| 23 |
F De Vita, M Orditura, E Martinelli, L Vecchione, R Innocenti, V C Sileni, C Pinto, M Di Maio, A Farella, T Troiani, F Morgillo, V Napolitano, E Ancona, N Di Martino, A Ruol, G Galizia, A Del Genio, F Ciardiello. A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer. British Journal of Cancer 2011; 104(3): 427 doi: 10.1038/sj.bjc.6606093
|
| 24 |
Alexandra D. Dreyfuss, Anastasia Velalopoulou, Harris Avgousti, Brett I. Bell, Ioannis I. Verginadis. Preclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkers. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.920867
|
| 25 |
Grzegorz Ćwik, Andrzej Dąbrowski, Tomasz Skoczylas, Grzegorz Wallner. Imaging of the Cervical and Abdominal Lymph Nodes in a Combined Treatment of Squamous Cell Oesophageal Carcinoma. Polish Journal of Surgery 2011; 83(2) doi: 10.2478/v10035-011-0015-7
|
| 26 |
E Tanaka, H Okabe, S Tsunoda, K Obama, T Kan, Y Kadokawa, M Akagami, Y Sakai. Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy. Asian Journal of Endoscopic Surgery 2012; 5(3): 111 doi: 10.1111/j.1758-5910.2012.00131.x
|
| 27 |
Pankaj Kumar Garg, Jyoti Sharma, Ashish Jakhetiya, Aakanksha Goel, Manish Kumar Gaur. Preoperative therapy in locally advanced esophageal cancer. World Journal of Gastroenterology 2016; 22(39): 8750-8759 doi: 10.3748/wjg.v22.i39.8750
|
| 28 |
SUSUMU SAIGUSA, KOJI TANAKA, MASAKI OHI, YUJI TOIYAMA, HIROMI YASUDA, TAKAHITO KITAJIMA, YOSHINAGA OKUGAWA, YASUHIRO INOUE, YASUHIKO MOHRI, MASATO KUSUNOKI. Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. Molecular and Clinical Oncology 2015; 3(1): 151 doi: 10.3892/mco.2014.431
|
| 29 |
Ali Sadrizadeh, Reza Bagheri, Ehsan Soltani, Kazem Anvari, Mehdi Seilanian Toussi, Soheila Moadikhah. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer Patients. Journal of Gastrointestinal Cancer 2018; 49(1): 50 doi: 10.1007/s12029-016-9899-0
|
| 30 |
K. Maruyama, S. Motoyama, A. Anbai, S. Usami, Y. Sato, K. Shibuya, K. Yoshino, T. Nakatsu, Y. Minamiya, J.-I. Ogawa. Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. Diseases of the Esophagus 2011; 24(3): 166 doi: 10.1111/j.1442-2050.2010.01119.x
|
| 31 |
Giovanni de Manzoni, Andrea Zanoni, Jacopo Weindelmayer. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma. Updates in Surgery 2012; : 161 doi: 10.1007/978-88-470-2330-7_14
|
| 32 |
A.M. Reece‐Smith, S. Saha, M.L. Cunnell, K. Hameed, E.M. Bessell, J.P. Duffy, S. Madhusudan, S.L. Parsons. MAGIC in practice: Experience of peri‐operative ECF/X chemotherapy in gastro‐esophageal adenocarcinomas. Journal of Surgical Oncology 2012; 106(6): 748 doi: 10.1002/jso.23187
|
| 33 |
J. Huang, S.‐Y. Zhang, Y.‐M. Gao, Y.‐F. Liu, Y.‐B. Liu, Z.‐G. Zhao, K. Yang. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Proliferation 2014; 47(4): 277 doi: 10.1111/cpr.12109
|
| 34 |
Katrin Schwameis, Joerg Zehetner, Jeffrey A. Hagen, Daniel S. Oh, Stephanie G. Worrell, Kais Rona, Nathan Cheng, Jamil Samaan, Kyle M. Green, John C. Lipham. Esophageal adenocarcinoma stage III: Survival based on pathological response to neoadjuvant treatment. Surgical Oncology 2017; 26(4): 522 doi: 10.1016/j.suronc.2017.10.001
|
| 35 |
K Kumagai, I Rouvelas, J A Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, L Lundell, M Nilsson. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. British Journal of Surgery 2014; 101(4): 321 doi: 10.1002/bjs.9418
|
| 36 |
Xiaowu Zhong, Guangcheng Huang, Qiang Ma, Hebin Liao, Chang Liu, Wenjie Pu, Lei Xu, Yan Cai, Xiaolan Guo. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. Medicine 2019; 98(27): e16269 doi: 10.1097/MD.0000000000016269
|
| 37 |
Arzu Oezcelik, Gernot M. Kaiser, Wolfgang Niebel, Christopher Sleyman, Juergen W. Treckmann, Georgios C. Sotiropoulos, Renate Reinhardt, Tanja Trarbach, Eugen Malamutmann, Andreas Paul. Ten‐year survival of esophageal cancer after an en‐bloc esophagectomy. Journal of Surgical Oncology 2012; 105(3): 284 doi: 10.1002/jso.22096
|
| 38 |
Jin Zhou, Hai-Ping Lin, Xin Xu, Xiao-Hang Wang, Ling Rong, Yao Zhang, Lei Shen, Lei Xu, Wei-Ting Qin, Qing Ye, Xiu-Mei Ma, Yong-Rui Bai. The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1041126
|
| 39 |
B. Mungo, D. Molena, M. Stem, S. C. Yang, R. J. Battafarano, M. V. Brock, A. O. Lidor. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?. Diseases of the Esophagus 2015; 28(7): 644 doi: 10.1111/dote.12251
|
| 40 |
Thomas Steffen, Daniel Dietrich, Annelies Schnider, Christoph Kettelhack, Olivier Huber, Walter R. Marti, Markus Furrer, Beat Gloor, Marc Schiesser, Sandra Thierstein, Peter Brauchli, Thomas Ruhstaller. Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer. Annals of Surgery 2019; 269(1): 83 doi: 10.1097/SLA.0000000000002435
|
| 41 |
Florian Sterzing, Lars Grenacher, Jürgen Debus. Early Gastrointestinal Cancers. Recent Results in Cancer Research 2012; 196: 187 doi: 10.1007/978-3-642-31629-6_13
|
| 42 |
Tad Kim, Stephen R Grobmyer, Reshelle Smith, Kfir Ben‐David, Darwin Ang, Stephen B Vogel, Steven N Hochwald. Esophageal cancer—the five year survivors. Journal of Surgical Oncology 2011; 103(2): 179 doi: 10.1002/jso.21784
|
| 43 |
Charles Bakhos, Tolutope Oyasiji, Nassrene Elmadhun, Michael Kent, Sidhu Gangadharan, Jonathan Critchlow, Tom Fabian. Feasibility of Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiation. Journal of Laparoendoscopic & Advanced Surgical Techniques 2014; 24(10): 688 doi: 10.1089/lap.2014.0118
|
| 44 |
Christoph Pöttgen, Martin Stuschke. Radiotherapy versus surgery within multimodality protocols for esophageal cancer – A meta-analysis of the randomized trials. Cancer Treatment Reviews 2012; 38(6): 599 doi: 10.1016/j.ctrv.2011.10.005
|
| 45 |
Koichi Hayano, Kiyohiko Shuto, Asami Satoh, Tomoyoshi Aoyagi, Kazuo Narushima, Hisashi Gunji, Tsuguaki Kono, Noriyuki Yanagawa, Shinichi Okazumi, Hisahiro Matsubara. Tumor blood flow change measured by CT perfusion during chemoradiation therapy (CRT) for monitoring response and predicting survival in patients with esophageal cancer. Esophagus 2014; 11(1): 72 doi: 10.1007/s10388-013-0400-x
|
| 46 |
Susumu Saigusa, Koji Tanaka, Masaki Ohi, Yoshito Ishino, Hiromi Yasuda, Yoshinaga Okugawa, Yuji Toiyama, Yasuhiro Inoue, Keiichi Uchida, Yasuhiko Mohri, Masato Kusunoki. Clinical significance of peritumoral mast cells in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. Esophagus 2013; 10(1): 12 doi: 10.1007/s10388-012-0356-2
|
| 47 |
Andrea Zanoni, Giuseppe Verlato, Simone Giacopuzzi, Massimiliano Motton, Francesco Casella, Jacopo Weindelmayer, Elena Ambrosi, Alberto Di Leo, Antonios Vassiliadis, Francesco Ricci, Thomas W. Rice, Giovanni de Manzoni. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer. Annals of Surgical Oncology 2016; 23(S5): 998 doi: 10.1245/s10434-016-5440-8
|
| 48 |
Shenglei Li, Hongtao Liu, Changying Diao, Xiaohui Wang, Ming Gao, Zongming Li, Lijie Song, Xianzheng Gao, Jing Han, Feng Wang, Wencai Li, Xinwei Han. Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis. Oncotarget 2017; 8(22): 36339 doi: 10.18632/oncotarget.16193
|
| 49 |
M. Stahl, T. Ruhstaller. Multimodale Therapie des Ösophaguskarzinoms. Der Internist 2014; 55(1): 7 doi: 10.1007/s00108-013-3315-7
|
| 50 |
Andrea Zanoni, Simone Giacopuzzi, Silvia Laiti, Alberto Di Leo, Giovanni de Manzoni. Adenocarcinoma of the Esophagogastric Junction. 2017; : 117 doi: 10.1007/978-3-319-28776-8_14
|
| 51 |
M. Orditura, G. Galizia, F. Morgillo, E. Martinelli, E. Lieto, F. Vitiello, N. Di Martino, R. Pacelli, A. Renda, F. Ciardiello, F. De Vita. Complete response to preoperative chemoradiation and survival in esophageal cancer: a pooled analysis of three single-institution phase II trials. Diseases of the Esophagus 2012; 25(2): 130 doi: 10.1111/j.1442-2050.2011.01220.x
|
| 52 |
Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi. Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis. Digestive Diseases and Sciences 2012; 57(12): 3226 doi: 10.1007/s10620-012-2263-8
|
| 53 |
Khashayar Fakhrian, Arif Deniz Ordu, Florian Lordick, Jörg Theisen, Bernhard Haller, Tomislav Omrčen, Michael Molls, Carsten Nieder, Hans Geinitz. Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU. Strahlentherapie und Onkologie 2014; 190(12): 1133 doi: 10.1007/s00066-014-0711-4
|
| 54 |
Johannes Zacherl. The Current Evidence in Support of Multimodal Treatment of Locally Advanced, Potentially Resectable Esophageal Cancer. Digestive Diseases 2014; 32(1-2): 171 doi: 10.1159/000357189
|
| 55 |
Xin Nie, Shuya He, Xinming Nie, Changding Li, Kunyi Du, Wenwu He, Zhiyu Li, Kunhan Ni, Simiao Lu, Chenghao Wang, Kangning Wang, Yan Miao, Longlin Jiang, Jiahua Lv, Guangyuan Liu, Qiang Fang, Lin Peng, Wenguang Xiao, Qifeng Wang, Dongsheng Wang, Yongtao Han, Xuefeng Leng. Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1320282
|
| 56 |
C. Pöttgen, M. Stuschke. Multimodale Therapie beim Plattenepithelkarzinom des Ösophagus. Der Onkologe 2010; 16(5): 496 doi: 10.1007/s00761-010-1829-3
|